Randall W Moreadith - Net Worth and Insider Trading

Randall W Moreadith Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Randall W Moreadith owns 1 companies in total, including Nektar Therapeutics (NKTR) .

Click here to see the complete history of Randall W Moreadith’s form 4 insider trades.

Insider Ownership Summary of Randall W Moreadith

Ticker	Comapny	Transaction Date	Type of Owner
NKTR	Nektar Therapeutics	2008-08-11	SVP Drug Development

Randall W Moreadith Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Randall W Moreadith Ownership Network

Ownership Network List of Randall W Moreadith

No Data

Ownership Network Relation of Randall W Moreadith

Randall W Moreadith Owned Company Details

What does Nektar Therapeutics do?

Who are the key executives at Nektar Therapeutics?

Randall W Moreadith is the SVP Drug Development of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .

Nektar Therapeutics (NKTR) Insider Trades Summary

Over the past 18 months, Randall W Moreadith made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 111,800 shares made by Howard W Robin , a net sale of 52,375 shares made by Jonathan Zalevsky , and a net sale of 41,460 shares made by Mark Andrew Wilson .

In summary, during the past 3 months, insiders sold 27,398 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 27,398 shares. During the past 18 months, 289,853 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 289,853 shares.

Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nektar Therapeutics Insider Transactions

No Available Data

Randall W Moreadith Mailing Address

Above is the net worth, insider trading, and ownership report for Randall W Moreadith. You might contact Randall W Moreadith via mailing address: C/o Nektar Therapeutics, 201 Industrial Road, San Carlos Ca 94070.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.